岭南急诊医学杂志2024,Vol.29Issue(5) :532-534.DOI:10.3969/j.issn.1671-301X.2024.05.023

不同克隆号Ki-67对乳腺癌免疫组化染色的性能分析

Performance Analysis of Immunohistochemical Staining for Breast Cancer using Different Ki-67 Clones

陈耿标 刘映芬 李海刚 孙情 沈溪明 杨敏
岭南急诊医学杂志2024,Vol.29Issue(5) :532-534.DOI:10.3969/j.issn.1671-301X.2024.05.023

不同克隆号Ki-67对乳腺癌免疫组化染色的性能分析

Performance Analysis of Immunohistochemical Staining for Breast Cancer using Different Ki-67 Clones

陈耿标 1刘映芬 2李海刚 1孙情 1沈溪明 1杨敏1
扫码查看

作者信息

  • 1. 中山大学孙逸仙纪念医院病理科(510120)
  • 2. 广东省中医院
  • 折叠

摘要

目的:研究不同克隆号 Ki-67 在乳腺浸润性导管癌组织的表达百分比.方法:收集2022年-2023年,中山大学孙逸仙纪念医院病理科收录的45 例乳腺浸润性导管癌患者资料,采用免疫组化方法对其Ki-67表达情况进行探讨,通过对比分析,比较不同克隆号Ki-67在乳腺癌中增值指数百分比的差异.结果:本次45例分析结果得出抗体克隆号分组中,MIB1、C3G4、30-9和UMAB107组 Ki-67增殖指数百分比分别为10.97(5.12,27.82)、4.74(2.17,14.97)、16.09(4.73,29.51)和9.87(4.24,26.56),差异有统计学意义.结论:抗体克隆号的选择对乳腺癌中Ki-67免疫组化染色结果有较大影响,不同克隆号Ki-67抗体在乳腺癌中的增值指数百分比有显著性差异,Ki-67(30-9)和(MIB1)克隆号在乳腺癌中具有较高且稳定的表达,推荐在乳腺癌Ki-67免疫组化检测流程中使用30-9和MIB1这两个克隆号.

Abstract

Objective:To investigate the expression percentage of different Ki-67 clones in breast invasive ductal carcinoma tissue.Methods:Data from 45 patients with invasive ductal carcinoma of the breast admitted to the Depart-ment of Pathology at Sun Yat-sen Memorial Hospital of Sun Yat sen University from 2022 to 2023 were collected.Immu-nohistochemical methods were used to explore the expression of Ki-67 in these patients.Through comparative analysis,the difference of increment index percentage of different clone Ki-67 in breast cancer was compared.Results:In this analysis of 45 cases,statistically significant differences werenoticed between the median proliferation index of Ki-67 in MIB1,C3G4,30-9,and UMAB107(the median proliferation index,10.97,4.74,16.09,and 9.87,respectively).Con-clusion:The selection of antibody clone has great influence on Ki-67 immunohistochemical staining results in breast can-cer,The percentage of positive cells of Ki-67 antibodies with different clones in breast cancer was significantly different,Ki-67(30-9)and(MIB1)have high and stable expression in breast cancer.It is recommended to use 30-9 and MIB1 in breast cancer Ki-67 immunohistochemical detection process.

关键词

乳腺浸润性导管癌/不同克隆号Ki-67/一致性分析

Key words

invasive ductal carcinoma/Ki-67 antibody/multivariate analysis

引用本文复制引用

出版年

2024
岭南急诊医学杂志
广东省医学会

岭南急诊医学杂志

影响因子:0.437
ISSN:1671-301X
段落导航相关论文